- 全部删除
 
您的购物车当前为空
BML-259 是 CDK5 和 CDK2 的抑制剂,IC50 分别为 64 和 98 nM。 BML-259 可用于癌症和神经退行性疾病治疗的研究。


为众多的药物研发团队赋能,
让新药发现更简单!
BML-259 是 CDK5 和 CDK2 的抑制剂,IC50 分别为 64 和 98 nM。 BML-259 可用于癌症和神经退行性疾病治疗的研究。
| 规格 | 价格 | 库存 | 数量 | 
|---|---|---|---|
| 1 mg | ¥ 259  | In stock | |
| 5 mg | ¥ 587  | In stock | |
| 10 mg | ¥ 995  | In stock | |
| 25 mg | ¥ 2,230  | In stock | |
| 50 mg | ¥ 3,830  | In stock | |
| 100 mg | ¥ 5,480  | In stock | |
| 500 mg | ¥ 11,300  | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 683  | In stock | 
BML-259 相关产品
| 产品描述 | BML-259 is an inhibitor of CDK5 and CDK2 with IC50s of 64 and 98 nM, respectively. BML-259 can be used in studies about the treatment of cancer and neurodegenerative diseases.  | 
| 体外活性 | BML-259 prevents a large population of cells from NAC-evoked cell death[1].  | 
| 别名 | CAY10554 | 
| 分子量 | 260.35 | 
| 分子式 | C14H16N2OS | 
| CAS No. | 267654-00-2 | 
| Smiles | CC(C)c1cnc(NC(=O)Cc2ccccc2)s1 | 
| 密度 | no data available | 
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | 
| 溶解度信息 | DMSO:PBS (pH 7.2)(1:2): 0.3 mg/mL (1.15 mM), Sonication is recommended.  DMF: 30 mg/mL (115.23 mM), Sonication is recommended.  DMSO: 120 mg/mL (460.92 mM), Sonication is recommended.  Ethanol: 0.25 mg/mL (0.96 mM), Sonication is recommended.   | 
评论内容